Skip to main content
$117.26 $0.83 (0.7%)

04:00 PM EDT on 09/27/21

CRISPR Therapeutics (NASDAQ:CRSP)

CAPS Rating: 4 out of 5

Current Price $117.26 Mkt Cap $8.9B
Open $116.17 P/E Ratio 19.19
Prev. Close $117.26 Div. (Yield) $0.00 (0.0%)
Daily Range $113.32 - $117.84 Volume 91
52-Wk Range $79.31 - $220.20 Avg. Daily Vol. 1,017,525

Caps

How do you think NASDAQ:CRSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

439 Outperform
7 Underperform
 

All-Star Players

147 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CRSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dcclf (< 20)
Submitted November 01, 2019

Crispr Therapeutics AG (CRSP) is a very professional outfit. Since its de novo in late 2016, the company has always presented itself in the most intelligible, concise, and scrupulous manner. From international conference presentations to downloadable… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRSP VS S&P 500 (SPY)

NASDAQ:CRSP Summary

Fools bullish on NASDAQ:CRSP are also bullish on:

Fools bearish on NASDAQ:CRSP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRSP.

Recs

0
Member Avatar AureamUnam (< 20) Submitted: 8/6/2021 2:37:54 AM : Outperform Start Price: $134.28 NASDAQ:CRSP Score: -12.81

The only way is up. There are many diseases that can be treated by gene editing, and owning one of the main editing systems will ensure that success in due course.

Recs

0
Member Avatar holdsteady (49.70) Submitted: 8/5/2021 1:44:12 AM : Outperform Start Price: $126.99 NASDAQ:CRSP Score: -8.22

Gene editing is still in the early innings

Recs

0
Member Avatar CMFLovePeace (74.59) Submitted: 8/4/2021 8:03:31 AM : Outperform Start Price: $120.83 NASDAQ:CRSP Score: -3.47

Must have for any portfolio or gene editing basket. Only a nucleotide is needed.

Leaderboard

Find the members with the highest scoring picks in CRSP.

Score Leader

CMFMLove

CMFMLove (77.07) Score: +650.19

I'm generally bad at CAPS but I may have gotten this pick right. There's a long way to go, however, until we see commercial results from this technology.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CMFMLove 77.07 6/13/2017 Outperform 5Y $14.10 +731.63% +81.45% +650.19 1 Comment
Momentum21 36.31 10/24/2016 Outperform 5Y $14.05 +734.59% +106.11% +628.48 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $15.13 +675.02% +81.36% +593.65 0 Comment
prankjt17530 65.19 2/13/2017 Outperform 5Y $15.21 +670.94% +90.75% +580.19 0 Comment
SHOPNVDA < 20 6/26/2017 Outperform 5Y $16.84 +596.32% +81.50% +514.81 0 Comment
Capitalism 89.96 5/15/2017 Outperform 5Y $17.05 +587.74% +84.36% +503.38 1 Comment
TMFFishBiz 60.93 11/13/2017 Outperform 5Y $17.91 +554.72% +71.39% +483.33 0 Comment
JF9383 76.16 12/6/2017 Outperform 5Y $18.44 +535.90% +68.41% +467.49 0 Comment
jeepdrew222 75.00 12/12/2017 Outperform 5Y $18.61 +530.09% +66.07% +464.02 0 Comment
portefeuille 98.63 3/27/2017 Outperform 5Y $18.50 +533.84% +90.87% +442.97 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRSP.